The 11th Annual Drug Discovery Leaders Summit is an exclusive event designed specifically for the most senior level drug discovery practitioners from the world’s leading pharmaceutical and biotechnology companies. This exclusive event consists of world-class keynote addresses, panel discussions and think tank sessions on all aspects of Drug discovery as well as highly targeted one-to-one business meetings.
Attending delegates are determined by specific criteria such as size of company, scope of responsibility and annual budget expenditure.
Delegates will be CSO’s, Vice Presidents, Directors and Heads of:
- Drug Discovery R&D
- Research
- Biotechnology
- Portfolio and Productivity Strategist
- Open Innovation
- Strategic Alliances
- External Science and Licensing
- Business Development
- Medicinal Chemistry
- Drug Design
- GPCR’s
- Computational Chemistry
- Screening
- HTS
- HCS
- Enabling Technologies
- RNAi
- Lead Optimisation
- Pharmacology
- Biomarkers
- Translational Medicine
- Exploratory medicine
- Personalised Medicine
- Diagnostics
- Imaging
- Safety
- Toxicology/Toxicogenomics
- Proteomics/Genomics/Metabolomics
- Bioinformatics
- Systems Biology
- Drug Metabolism/Pharmacokinetics (DMPK
- Pharmacokinetics/Pharmacodynamics (PKPD)
- Molecular and Cell Biology
- Structural Biology
- Data management
- Insilico Approaches
- Biologics
Delegates will benefit from:
- An executive format providing intimate interaction with industry peers’ ideas and experiences through case study presentations and panel discussions
- Networking opportunities and sharing ideas with other senior Drug Discovery practitioners
- Pre-scheduled one-to-one meetings between you and solution providers will provide you with an opportunity to forge partnerships and discover solutions
- Post event follow up offering all documentation from the meeting and re-booking discounts
- Tailor-made agenda – hand pick any conference and panel sessions you wish to attend
Delegates
